Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Class A common stock, $0.001 par value
-
Shares outstanding
-
162,474,849
-
Total 13F shares
-
330,881
-
Share change
-
+67,312
-
Total reported value
-
$2,233,000
-
Price per share
-
$6.75
-
Number of holders
-
12
-
Value change
-
+$455,099
-
Number of buys
-
8
-
Number of sells
-
3
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) as of Q3 2021
As of 30 Sep 2021,
IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
330,881 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, STATE STREET CORP, BlackRock Inc., TWO SIGMA ADVISERS, LP, RENAISSANCE TECHNOLOGIES LLC, Tower Research Capital LLC (TRC), ROYAL BANK OF CANADA, and MORGAN STANLEY.
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.